---
figid: PMC7905684__10020_2021_279_Fig1_HTML
figtitle: Novel targeted therapies for Parkinson’s disease
organisms:
- NA
pmcid: PMC7905684
filename: 10020_2021_279_Fig1_HTML.jpg
figlink: pmc/articles/PMC7905684/figure/Fig1/
number: F1
caption: Potential neuroprotective mechanisms of novel targeted therapies in Parkinson’s
  disease.AAV adeno-associated virus, AP area postrema, A2AR adenosine A2A receptor,
  Cd caudate nucleus, DA cell dopaminergic cell, DBS deep brain stimulation, dMSN direct
  pathway medium spiny neurons, D1R dopamine D1 receptor; D2R dopamine D2 receptor;
  GAD glutamate decarboxylase; GCase glucocerebrosidase, GDNF glial cell-line derived
  neurotrophic factor, GLP1R glucagon-like peptide 1 receptor, GPe globus pallidus
  externa, GPi globus pallidus interna, iMSN indirect pathway medium spiny neurons;
  KI kinase inhibitor, LB lewy body, LRRK2 leukine-rich repeat kinase 2, MG microglia,
  NM neuromelanin; PrCG pre-central gyus, Pu putamen; SNC substantia nigra pars compacta,
  SNR substantia nigra pars reticulata, STN subthalamic nucleus, TMS transcranial
  magnetic stimulation
papertitle: Novel targeted therapies for Parkinson’s disease.
reftext: Theodora Ntetsika, et al. Mol Med. 2021;27:17.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7618403
figid_alias: PMC7905684__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC7905684__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7905684__10020_2021_279_Fig1_HTML.html
  '@type': Dataset
  description: Potential neuroprotective mechanisms of novel targeted therapies in
    Parkinson’s disease.AAV adeno-associated virus, AP area postrema, A2AR adenosine
    A2A receptor, Cd caudate nucleus, DA cell dopaminergic cell, DBS deep brain stimulation,
    dMSN direct pathway medium spiny neurons, D1R dopamine D1 receptor; D2R dopamine
    D2 receptor; GAD glutamate decarboxylase; GCase glucocerebrosidase, GDNF glial
    cell-line derived neurotrophic factor, GLP1R glucagon-like peptide 1 receptor,
    GPe globus pallidus externa, GPi globus pallidus interna, iMSN indirect pathway
    medium spiny neurons; KI kinase inhibitor, LB lewy body, LRRK2 leukine-rich repeat
    kinase 2, MG microglia, NM neuromelanin; PrCG pre-central gyus, Pu putamen; SNC
    substantia nigra pars compacta, SNR substantia nigra pars reticulata, STN subthalamic
    nucleus, TMS transcranial magnetic stimulation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ida
  - tms
  - stnA
  - stnB
  - Abl
  - Lrrk
  - Ki
  - cd
  - Pu
  - cav
  - da
  - nAChRalpha2
  - gr
  - Pgi
  - Snr1
  - pd
  - E(spl)mgamma-HLH
  - Ubqn
  - mol
  - moi
  - mor
  - Dop2R
  - Dop1R2
  - Si
  - ap
  - msn
  - GDNF
  - IDUA
  - TYMS
  - PYCARD
  - EEF1A2
  - LRP2
  - PRH1
  - MCF2L
  - ABL1
  - LRRK2
  - CA5A
  - CAV2
  - CAV1
  - CAV3
  - GPI
  - GNPDA1
  - NM
  - DUOXA1
  - DRD2
  - GLP1R
  - DRD1
  - SI
  - ADORA2A
  - MSN
  - Isradipine
  - Cd
  - PD
  - SI
---
